267 related articles for article (PubMed ID: 29370830)
1. A comparison of meta-analytic methods for synthesizing evidence from explanatory and pragmatic trials.
Sajobi TT; Li G; Awosoga O; Wang M; Menon BK; Hill MD; Thabane L
Syst Rev; 2018 Jan; 7(1):19. PubMed ID: 29370830
[TBL] [Abstract][Full Text] [Related]
2. Do randomized controlled nursing trials have a pragmatic or explanatory attitude? Findings from the Pragmatic-Explanatory Continuum Indicator Summary (PRECIS) tool exercise.
Palese A; Bevilacqua MG; Dante A;
J Nurs Res; 2014 Sep; 22(3):216-20. PubMed ID: 25111115
[TBL] [Abstract][Full Text] [Related]
3. The role of pragmatism in explaining heterogeneity in meta-analyses of randomised trials: a protocol for a cross-sectional methodological review.
Aves T; Allan KS; Lawson D; Nieuwlaat R; Beyene J; Mbuagbaw L
BMJ Open; 2017 Sep; 7(9):e017887. PubMed ID: 28871028
[TBL] [Abstract][Full Text] [Related]
4. Pragmatic vs. explanatory: an adaptation of the PRECIS tool helps to judge the applicability of systematic reviews for daily practice.
Koppenaal T; Linmans J; Knottnerus JA; Spigt M
J Clin Epidemiol; 2011 Oct; 64(10):1095-101. PubMed ID: 21474282
[TBL] [Abstract][Full Text] [Related]
5. A dynamic application of PRECIS-2 to evaluate implementation in a pragmatic, cluster randomized clinical trial in two nursing home systems.
Palmer JA; Mor V; Volandes AE; McCreedy E; Loomer L; Carter P; Dvorchak F; Mitchell SL
Trials; 2018 Aug; 19(1):453. PubMed ID: 30134976
[TBL] [Abstract][Full Text] [Related]
6. Framing the conversation: use of PRECIS-2 ratings to advance understanding of pragmatic trial design domains.
Lipman PD; Loudon K; Dluzak L; Moloney R; Messner D; Stoney CM
Trials; 2017 Nov; 18(1):532. PubMed ID: 29126437
[TBL] [Abstract][Full Text] [Related]
7. Study characteristics impacted the pragmatism of randomized controlled trial published in nursing: a meta-epidemiological study.
Devos F; Foissac F; Bouazza N; Ancel PY; Tréluyer JM; Chappuy H
J Clin Epidemiol; 2019 Dec; 116():18-25. PubMed ID: 31374332
[TBL] [Abstract][Full Text] [Related]
8. Making clinical trials more relevant: improving and validating the PRECIS tool for matching trial design decisions to trial purpose.
Loudon K; Zwarenstein M; Sullivan F; Donnan P; Treweek S
Trials; 2013 Apr; 14():115. PubMed ID: 23782862
[TBL] [Abstract][Full Text] [Related]
9. Using the Pragmatic-Explanatory Continuum Indicator Summary (PRECIS) model in clinical research: Application to refine a practice-based research network (PBRN) study.
Elder WG; Munk N
J Am Board Fam Med; 2014; 27(6):846-54. PubMed ID: 25381083
[TBL] [Abstract][Full Text] [Related]
10. Integrating pragmatic and implementation science randomized clinical trial approaches: a PRagmatic Explanatory Continuum Indicator Summary-2 (PRECIS-2) analysis.
Zatzick D; Palinkas L; Chambers DA; Whiteside L; Moloney K; Engstrom A; Prater L; Russo J; Wang J; Abu K; Iles-Shih M; Bulger E
Trials; 2023 Apr; 24(1):288. PubMed ID: 37085877
[TBL] [Abstract][Full Text] [Related]
11. [The PRECIS-2 tool: designing trials that are fit for purpose].
Hu GP; Zhan SY
Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Feb; 39(2):222-226. PubMed ID: 29495210
[TBL] [Abstract][Full Text] [Related]
12. Designing provider-focused implementation trials with purpose and intent: introducing the PRECIS-2-PS tool.
Norton WE; Loudon K; Chambers DA; Zwarenstein M
Implement Sci; 2021 Jan; 16(1):7. PubMed ID: 33413489
[TBL] [Abstract][Full Text] [Related]
13. The PRECIS-2 tool seems not to be useful to discriminate the degree of pragmatism of medicine masked trials from that of open-label trials.
Dal-Ré R
Eur J Clin Pharmacol; 2021 Apr; 77(4):539-546. PubMed ID: 33106910
[TBL] [Abstract][Full Text] [Related]
14. A pragmatic-explanatory continuum indicator summary (PRECIS): a tool to help trial designers.
Thorpe KE; Zwarenstein M; Oxman AD; Treweek S; Furberg CD; Altman DG; Tunis S; Bergel E; Harvey I; Magid DJ; Chalkidou K
J Clin Epidemiol; 2009 May; 62(5):464-75. PubMed ID: 19348971
[TBL] [Abstract][Full Text] [Related]
15. Real-world evidence: How pragmatic are randomized controlled trials labeled as pragmatic?
Dal-Ré R; Janiaud P; Ioannidis JPA
BMC Med; 2018 Apr; 16(1):49. PubMed ID: 29615035
[TBL] [Abstract][Full Text] [Related]
16. [Progress in research of pragmatic-explanatory continuum indicator summary].
Hu G; Hu Y; Zhan S
Zhonghua Liu Xing Bing Xue Za Zhi; 2016 Mar; 37(3):439-42. PubMed ID: 27005554
[TBL] [Abstract][Full Text] [Related]
17. How pragmatic are randomized trials of remdesivir and favipiravir for in-hospital treatment of COVID-19: a descriptive methodological review of trial design using the PRECIS-2 framework.
Sharma T; Qamar I; Zwarenstein M
J Clin Epidemiol; 2022 Dec; 152():193-200. PubMed ID: 36265553
[TBL] [Abstract][Full Text] [Related]
18. Are trials of psychological and psychosocial interventions for schizophrenia and psychosis included in the NICE guidelines pragmatic? A systematic review.
Gastaldon C; Mosler F; Toner S; Tedeschi F; Bird VJ; Barbui C; Priebe S
PLoS One; 2019; 14(9):e0222891. PubMed ID: 31550279
[TBL] [Abstract][Full Text] [Related]
19. Effect of pragmatic versus explanatory interventions on medication adherence in people with cardiometabolic conditions: a systematic review and meta-analysis.
Fitzpatrick C; Gillies C; Seidu S; Kar D; Ioannidou E; Davies MJ; Patel P; Gupta P; Khunti K
BMJ Open; 2020 Jul; 10(7):e036575. PubMed ID: 32709649
[TBL] [Abstract][Full Text] [Related]
20. The application of PRECIS-2 ratings in randomized controlled trials of Chinese herbal medicine.
Lu L; Zhou L; Dong J; Xiang Y; Wen Z
Oncotarget; 2017 Dec; 8(63):107002-107010. PubMed ID: 29291006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
